Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Todoroki

Showing results (131-140 of 187) with videos related to

Pageof 19
Sort By:
Cancer|November 15, 1980
Intraoperative radiotherapy for advanced carcinoma of the biliary systemT Todoroki, Y Iwasaki, T Okamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladderT Kawamoto, J Shoda, T Irimura, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
Secretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors of chronic proliferative cholangitisJ Shoda, M Kano, T Asano, et al.
Hepato-Gastroenterology|July 21, 2001
Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancerK Ohara, H Tatsuzaki, N G Molotkova, et al.
International Journal of Molecular Medicine|October 13, 2000
Cyclooxygenase expression in the gallbladderM Ghosh, T Kawamoto, N Koike, et al.
The American Journal of Gastroenterology|January 5, 2002
The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory functionJ Shoda, M Kano, K Oda, et al.
Biochemical and Biophysical Research Communications|March 13, 2001
Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humansK Moriya, T Todoroki, T Tsutsumi, et al.
Transplantation Proceedings|December 20, 2000
Inhibition of CD95 ligand-mediated inflammationK Seino, T Tun, N Ohshima, et al.
Annals of Surgery|October 31, 2001
Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activationK Seino, Y Setoguchi, T Ogino, et al.
Cancer Research|June 5, 2001
Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesisK Moriya, K Nakagawa, T Santa, et al.
Pageof 19

Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
Cancer|November 15, 1980
Intraoperative radiotherapy for advanced carcinoma of the biliary systemT Todoroki, Y Iwasaki, T Okamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladderT Kawamoto, J Shoda, T Irimura, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
Secretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors of chronic proliferative cholangitisJ Shoda, M Kano, T Asano, et al.
Hepato-Gastroenterology|July 21, 2001
Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancerK Ohara, H Tatsuzaki, N G Molotkova, et al.
International Journal of Molecular Medicine|October 13, 2000
Cyclooxygenase expression in the gallbladderM Ghosh, T Kawamoto, N Koike, et al.
The American Journal of Gastroenterology|January 5, 2002
The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory functionJ Shoda, M Kano, K Oda, et al.
Biochemical and Biophysical Research Communications|March 13, 2001
Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humansK Moriya, T Todoroki, T Tsutsumi, et al.
Transplantation Proceedings|December 20, 2000
Inhibition of CD95 ligand-mediated inflammationK Seino, T Tun, N Ohshima, et al.
Annals of Surgery|October 31, 2001
Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activationK Seino, Y Setoguchi, T Ogino, et al.
Cancer Research|June 5, 2001
Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesisK Moriya, K Nakagawa, T Santa, et al.
Pageof 19